NYSE$MOH
Molina Healthcare Inc · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
Reported GAAP EPS of $3.10 and adjusted EPS of $3.36.
Molina Healthcare reported a solid third quarter performance with increased premium revenue and improved medical care ratio. The company's net income increased to $185 million, and adjusted EPS reached $3.36.
- Premium revenue increased by 16.8% to $4.8 billion.
- Medical care ratio improved to 85.9% compared to 86.3% in the third quarter of 2019.
- General and administrative expense ratio decreased to 7.3% from 7.6%.
- Net income rose to $185 million, compared to $175 million in the same quarter of the previous year.
Headline financials
Revenue & EPS history
Molina · Revenue · Quarterly
$5.02B
Revenue by segment
Molina · $8.04B total across 3 segments · Q2 2023
- Medicaid$6.49B+2.9%80.6%
- Medicare$1.04B+9.1%13.0%
- Marketplace$513M-5.2%6.4%
Forward guidance
The Company has increased its full year 2020 total revenue guidance to approximately $19.6 billion. While the Company’s core performance is expected to remain strong through the fourth quarter of 2020, the Company is choosing to maintain its existing earnings guidance.
Tailwinds
- Full year 2020 total revenue guidance increased to approximately $19.6 billion.
- Revenue reflects the Passport membership.
- Revenue reflects higher Medicaid enrollment through the third quarter of 2020.
- Core performance is expected to remain strong through the fourth quarter of 2020.
- Magellan Complete Care acquisition is on track to close around the end of the year.
Headwinds
- Continued uncertainty related to COVID’s impact on medical care costs.
- Possibility for additional COVID-related rate refunds.
- Cautious approach due to uncertainty related to COVID.
- Marketplace MCR was negatively affected by COVID-related impacts.
- Marketplace MCR was negatively affected by some modest underachievement of risk scores relative to the acuity of certain Marketplace members.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2020
+0.2%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+2.9%
Avg return
30 days after
41%
27 / 66 earnings
Positive
+26.3%
Q1 2017
Best reaction
-25.5%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.6% | +21.2% | +20.3% | |
| Q4 2025 | -25.5% | -30.6% | -18.3% | |
| Q3 2025 | -17.3% | -16.5% | -27.5% | |
| Q2 2025 | +4.9% | +8.8% | +13.3% | |
| Q1 2025 | -5.5% | -3.7% | -8.1% | |
| Q4 2024 | -10.1% | -13.9% | +3.3% | |
| Q3 2024 | +14.0% | +11.0% | +2.4% | |
| Q2 2024 | +13.0% | +16.1% | +20.5% | |
| Q1 2024 | -3.0% | -5.3% | -8.6% | |
| Q4 2023 | +6.8% | +9.9% | +9.9% | |
| Q3 2023 | -0.7% | -1.7% | +10.1% | |
| Q2 2023 | -2.6% | -3.5% | +1.0% | |
| Q1 2023 | +6.3% | +9.4% | -2.2% | |
| Q4 2022 | -0.5% | -1.1% | -13.7% | |
| Q3 2022 | -3.9% | -2.0% | -10.7% | |
| Q2 2022 | +2.7% | +5.3% | +9.7% | |
| Q1 2022 | -1.9% | -4.7% | -5.1% | |
| Q4 2021 | -0.5% | -0.0% | +1.8% | |
| Q3 2021 | -0.8% | -0.5% | -2.4% | |
| Q2 2021 | -2.0% | +5.4% | +3.2% | |
| Q1 2021 | +1.2% | +2.2% | +0.2% | |
| Q4 2020 | +5.0% | +5.0% | +12.9% | |
| Q3 2020 | -8.2% | -2.5% | +1.5% | |
| Q2 2020 | -1.6% | -0.5% | -2.0% | |
| Q1 2020 | +5.2% | +9.9% | +12.8% | |
| Q4 2019 | +10.5% | +13.3% | +3.1% | |
| Q3 2019 | -0.3% | -4.4% | +11.0% | |
| Q2 2019 | -4.4% | -7.0% | -6.5% | |
| Q1 2019 | +0.9% | -0.2% | +2.0% | |
| Q4 2018 | -5.5% | -1.1% | +3.6% | |
| Q3 2018 | -0.8% | -0.9% | +11.1% | |
| Q2 2018 | +18.7% | +23.1% | +34.7% | |
| Q1 2018 | -2.9% | -1.2% | +3.4% | |
| Q4 2017 | -3.8% | -8.1% | -2.8% | |
| Q3 2017 | +16.1% | +13.7% | +14.6% | |
| Q2 2017 | -6.8% | -12.4% | -4.0% | |
| Q1 2017 | +26.3% | +30.8% | +31.3% | |
| Q4 2016 | -17.2% | +1.6% | -6.0% | |
| Q3 2016 | -5.9% | -7.0% | -9.3% | |
| Q2 2016 | +10.1% | +8.1% | +4.2% | |
| Q1 2016 | -20.6% | — | — | |
| Q4 2015 | -1.5% | — | — | |
| Q3 2015 | -8.6% | — | — | |
| Q2 2015 | +9.6% | — | — | |
| Q1 2015 | +11.6% | — | — | |
| Q4 2014 | +8.8% | — | — | |
| Q3 2014 | +4.6% | — | — | |
| Q2 2014 | -6.5% | — | — | |
| Q1 2014 | +4.5% | — | — | |
| Q4 2013 | -6.4% | — | — | |
| Q3 2013 | -7.5% | — | — | |
| Q2 2013 | -1.4% | — | — | |
| Q1 2013 | +1.6% | — | — | |
| Q4 2012 | +10.0% | — | — | |
| Q3 2012 | +14.3% | — | — | |
| Q2 2012 | -1.7% | — | — | |
| Q1 2011 | -2.5% | — | — | |
| Q1 2012 | +0.2% | — | — | |
| Q4 2011 | -0.2% | — | — | |
| Q1 2010 | -0.2% | — | — | |
| Q4 2009 | -0.2% | — | — | |
| Q3 2010 | +1.2% | — | — | |
| Q3 2011 | +1.2% | — | — | |
| Q2 2011 | -2.7% | — | — | |
| Q4 2010 | -2.7% | — | — | |
| Q2 2010 | -2.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro